Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL2837591 | 1.00 | ALDH1A1 (0.37) | ALDH1A1THRBLMNA | |
| Ether SCHEMBL8089271 | 1.00 | ALDH1A1 (0.37) | ALDH1A1THRBLMNA | |
| Ether SCHEMBL96502 | 1.00 | — | — | |
| Ether SCHEMBL3794585 | 1.00 | ALDH1A1 (0.37) | ALDH1A1THRBLMNA | |
| Ether SCHEMBL28734827 | 0.93 | ALDH1A1 (0.33) | ALDH1A1THRBLMNA | |
| Ether SCHEMBL422163 | 0.93 | ALDH1A1 (0.40) | ALDH1A1THRBLMNA | |
| Ether SCHEMBL9750502 | 0.92 | — | — | |
| Ether SCHEMBL4944310 | 0.89 | ALDH1A1 (0.45) | ALDH1A1THRB | |
| Ether SCHEMBL861634 | 0.88 | — | — | |
| 1,1,2,2-Tetrachloroethane SCHEMBL28191474 | 0.88 | TDP1 (0.39) | ALDH1A1THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120129963-A1 | SYNTHESIS OF NOVEL MULTIFUNCTIONAL CARDANOL'S DERIVATIVES AND THEIR USE AS HALOGEN FREE POLYURETHANIC FOAMS PRECURSORS | CIMTEC LAB S.P.A. (IT) | 2012-05-24 | — | — | US | disclosed |
| EP-2451762-A1 | SYNTHESIS OF NOVEL MULTIFUNCTIONAL CARDANOL'S DERIVATIVES AND THEIR USE AS HALOGEN FREE POLYURETHANIC FOAMS PRECURSORS | Cimteclab S.R.L. (IT) | 2012-05-16 | — | — | EP | disclosed |
| US-20080021069-A1 | Receptor Function Regulating Agent | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-01-24 | — | — | US | disclosed |
| EP-1810677-A1 | RECEPTOR FUNCTION REGULATING AGENT | Takeda Pharmaceutical Company Limited (JP) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021069-A1 | Receptor Function Regulating Agent | GPR119, INSR, GPR65 | ALDH1A1 1870/4885THRB 281/4885LMNA 4744/4885 |
| US-20120129963-A1 | SYNTHESIS OF NOVEL MULTIFUNCTIONAL CARDANOL'S DERIVATIVES AND THEIR USE AS HALOGEN FREE POLYURETHANIC FOAMS PRECURSORS | EBP, CYP51A1, HSD17B7 | ALDH1A1 1391/4885THRB 4048/4885LMNA 1864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.